Article Details
Retrieved on: 2024-09-07 04:31:25
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Evercore ISI analyst Umer Raffat maintained a Buy rating on Vor Biopharma (VOR – Research Report) today. The company's shares closed...
Article found on: markets.businessinsider.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here